Graphical abstract

Abbreviations: Hydrothymoquinone, HTQ; Thymoquinone, TQ; Dimmer of Thymoquinone, DTQ; SARSCoV, Severe Acute Respiratory Syndrome - corona virus; TLC, thin lyar chromatography
Keywords: Antiviral, SARSCoV-19, Thymoquinone, Dithymoquinone, Hydrothymoquinone
Abstract
Inflammation, oxidation, and compromised immunity all increase the dangers of COVID-19, whereas many pharmaceutical protocols may lead to increased immunity such as ingesting from sources containing vitamin E and zinc. A global search for natural remedies to fight COVID-19 has emerged, to assist in the treatment of this infamous coronavirus. Nigella satvia is a world-renowned plant, an esteemed herbal remedy, which can be used as a liquid medicine to increase immunity while decreasing the dangers of acute respiratory distress syndrome. Thymoqinone (TQ), dithymoqinone (DTQ) and thymohydroquinone (THQ), are major compounds of the essential oil contained in N.sativa. A current study aims to discover the antiviral activity of two compounds, Thymohydroquinone and Dithymoquinone, which are synthesized through simple chemical procedures, deriving from thymoquinone, which happens to be a major compound of Nigella sativa. A half-maximal cytotoxic concentration, “CC50”, was calculated by MTT assay for each individual drug, The sample showed anti-SARS-CoV-2 activity at non-cytotoxic nanomolar concentrations in vitro with a low selectivity index (CC50/IC50 = 31.74/23.15 = 1.4), whereby Dimthymoquinone shows high cytotoxicity.
1. Introduction
The severe acute respiratory syndrome, coronavirus-2 (SARS-CoV-2), known internationally as the cause of COVID-19, also known as the coronavirus, was declared a pandemic in March of 2020. The main goal, world-wide, has been to discovera drug withenough potential antiviral activity to face this pandemic and overcome it; a drug having limited side effects, unlike synthetic drugs which are known to have a variety of aftereffects. With that specific and lofty ambition, our team set outfor collective information regarding the potential of natural plants aspossible antivirals, and publishedsome papers in regards to the activity of medicinal plants which were previously used to treat SARS –CoV-19, due to their similarity and host receptor. Regrettably, SARS-CoV-19 has infected thousands of people whereby every single country has suffered huge losses. Moreover, the death rate with COVID-19 is higher than that of SAES-CoV and MERS-CoV-19 combined. Therefore, our ambitious task has proven quite difficult.
Seeds of Nigella sativa L. (also commonly known as black cumin or black seed) are widely used in traditional Islamic medicine and for culinary purposes worldwide. Nigella seed oil is becoming popular within the Islamic world and beyond. Composition of Nigella seed oil is known to be location-dependent. We investigated the composition of Nigella seed oil prepared by solvent- or by the cold press-extraction ofNigella seeds grown in Morocco. Oil extraction yield was 37% and 27% when solvent or cold press extraction methods were used, respectively. In terms of its oil major components, the composition of Nigella seed oil from Morocco is similar to that ofother Mediterranean countries, who are commonlyknown for their Nigella seed-oil quality [1].
The antibacterial activity of the essential oil of N.sativawas determined against a panel of strains of bacteria. The GC–MS analysis showed that the major constituents of the oil were monoterpene hydrocarbons and phenolic monoterpenes, whereby theresults of antibacterial activity confirmed the possibility of using Nigella sativaessential oils or some of their components in biological and pharmaceutical preparations [2].
To fight against coronavirus by using the constituents of Nigella sativa L, one important question is posed; Which partis the most important, the essential oil or the actual seed?
Many reviews were conducted on plants and their secondary metabolites, which have shown activity against SARS-CoV. Numerous scientific reports on the potential of plants and secondary metabolites against SARS-CoV infection, whereby many of the compounds had been studied through computational studies [4], [5], [6]. confirmed that the primary host receptor for SARS-CoV-2 is the human angiotensin-converting enzyme 2 (ACE2).
Ye et al. overviewed the existing knowledge about 7 human coronaviruses(HCoVs), with a focus on the history of their discoveriesas well as their zoonotic origins and interspecies transmissions. They also compared and contrasted the different HCoVs from a perspective of virus evolution and genome recombination [7].
Lo et al. reported their experience on the evaluation of SARS-CoV-2 RNA shedding in clinical specimens and clinical features of all 10 patients in Macau, and recommended the assessment of both fecal and respiratory specimens for enhancing diagnostic sensitivity becausethere were notany specific antiviral drugs available for the treatment of this sudden and lethal disease.Many drugs have been used in thistherapy. Yang et al. [8] reported that greater than 85% of COVID-19 patients in China have been receiving Traditional Chinese Medicine (TCM) treatment,and presented strong clinical evidence showing the beneficial effect of TCM in the treatment of thesepatients [8].
Zhou and Zhaopointed out the great importance of using therapeutic neutralizing antibodies (NAbs) to control the spread and re-emergence of SARS-CoV-2 and assert that the development of NAbsshould therefore be a high priority in future considerations [9].
The two main components of black seed essential oil, Thymoquinone (TQ) and Thymohydroquinone (THQ), were investigated for their antibacterial activity against Escherichia coli, Pseudomonas aeruginosa, Shigella flexneri, Salmonella typhimurium, Salmonella enteritidis and Staphylococcus aureus [10], [11].
Thymohydroquinone (2), also referred to as Dihydrothymoquinone or Hydrothymoquinone, is the phenolic hydroquinone derivative of Thymoquinon, Thymohydroquinone is the first reductive product of Thymoquinone, which is a significant co-product of the essential oil in Nigella sativa.
Several studies onthebiological activity of Thymoquinone have been discussed in literature; oxidative stress, hepatoprotection, the anti-tumor proliferation, the anti-inflammatory, the hypertension, the anti-microbial, neuropathy pain, gastroenterological, the kidney, renal, and the heart [12], [13], [14]. In contrast to Thymoquinone, there is no concern over Dithymoquinone or hydrothymoqunon.
N. sativa seeds contain 36 –38% fixed oil and low concentrations of some unusual unsaturated fatty acids. Different components were characterized from the oil: the major ones were TQ (28–57%) and para-cymene (7– 15%), whereaslow concentrations of the dimeric form of TQ (Dithymoquinone), and only a minimal quantity of Dihydrothymoquinone (DHTQ) were detected in the oil [15]. DHTQ could be formed in the body after TQ ingestion, following the action of reductases, as reported for DT-diaphorase, which catalyzes reduction of TQ to DHTQ in different organs [16].
Thymoquinone (TQ), the main, active ingredient of black seed oil, possesses antioxidant, anti-inflammatory, antiviral, antimicrobial, immunomodulatory and anticoagulant activities[17].
Using POM Theory, arelatively new computational method for virtually screening many compounds from natural source, we screened20 compounds derived from Nigella sativa, Artemisia herba alba and thymus. The choice of these plants, as previously discussed, was made basedon their role in traditional medicine for curing a variety of diseases, with special focus on influenza, fever, and colds. Unfortunately, only a few of these plants have been screened against SARS-CoV, with verylimited references reporting these plants as a possible antiviral source.From amongst these selected plants, we choose only 5 compounds, Thymole, Thymoquinone, Dithydrothymoqinon (DHQ) and Dithmoquinon (DTQ) and Artemisinin (ARTM) all show promising results. So, we beganthe work protocol by studying in vitro, antiviral activity of these compounds against COVID-19.
The aim of thiscurrent study is to understand and emphasize the potential antiviral activity of Thymohydroquinon (THQ), and dithymoquinon(DTQ), whereby themany papers study the effect of Nigella sativa as antiviral [1], [2], [3], [4], [5], [6], [7], [8], [9], [10], [11], [12], [13], [14], [15], [16], [17], [18].However, there is not a single study of antiviral compounds derived from this plant, documenting antiviral activity against SARS-Cov19.
2. Material and methods
2.1. Mterial and equipment
Thymoquinone, solvent, acetone, ethanol, glacial acetic acid and TLC , HPLC-grade methanol were purchased from Sigma–Aldrich.
FT IR Spectra (Brüker Tensor 27with ATR configuration), H1NMR (BrükerAvance 400 NMR spectrometer), UV–Visable spectra (Varian Cary® 50 Scan spectrometer in a 1.0 cm square cuvette).
2.2. Synthesis of compounds (1, 3)
Thymoquinone was used for synthesis two compound HTQ and DTQ.
2.3. Synthesis hydrothymoquinone HTQ (2)
Thymoquinone (0.50 g, 3.1 mmol) was dissolved in glacial acetic acid (10.0 mL). Zinc (0.75 g) powder was added, and the reaction mixture was stirred at room temperature for 12 h. The progress of the reaction was monitored by TLC. After completion of the reaction, acetic acid was concentrated under vacuum and neutralized by Na2CO3 (2 M solution, 50 mL). Then, dichloromethane (50 mL) was added, and the organic materials were partitioned between the two phases. The organic layer was separated, dried over anhydrous MgSO4, and evaporated under reduced pressure,the seprated compound was then purified by column chromatography using silica gel as the stationary phase and hexane:ethyl acetate (9:1) mobile phase. White solid, 288 mg, yield 60%. was optained [16].
2.4. Characterization of compound 2 HTQ
The obtained FTIR spectra of the bending alkane vibration band, the bending δ(C—H) vibration of the resultingabsorption band is displayed here [19]. The strong band appeared at 1231 cm−1 due to stretching vibrations of ν(C—O) of aromatic ether. The two medium absorption bands at 1124 cm−1 and 900 cm−1 attributed to bending vibration of δ (C C) of α,β-unsaturated alkene., broad band appears at 3300 cm−1 corresponding stretching vibrations of νOH . 1H NMR (CDCl3, 500 MHz, δ in ppm): 1.04–1.06 (d, j = 1.6, 6H), 1.98 (s, CH3), 3.3 (m, 1H,CH), 6.42 (d, CH, j = 2.4), 8.35 (d, CH, j = 2.4). MS detection show apeak at m/z 165 [M−H] corresponding to the formation of HTQ.Also the absence of peak at m/z 163 [M−H] relayed to TQ confirmed the complete reaction which also confirmed by comparison the compound by authentic sample on TLC System ethyl acetate:hexane (1:9). All spectral data confirmed the presence of pure HTQ compound, and its purity was confirmed by HPLC.
2.5. Synthesis of Dithymoquinone DTQ (3)
In a 500 mL glass beaker, compound 1 (0.50 g) was dissolved in 5.0 mLacetone. The bright yellow solution was gently rotated along the inner surfaces of the beaker until complete evaporation occurred, into a thin, crystalline layer. The resulting thin layer (solid state) of 1 was exposed to UV lamp (345 ƛ max) in a fume hood at room temperature. The reaction was found to be greater than 99% complete after 8 h. The photodimerization reaction was monitored by TLC. Crude product was dissolved in asmall amount of DCM, loaded on silica gel, and then purified by column chromatography using silica gel as the stationary phase and hexane:ethyl acetate (9:1) mobile phase. Compound (DTQ) was dissolved in a minimal volume of ethyl acetate, transferred to a smaller Erlenmeyer flask, and then evaporated to dryness over gentle heat. Crystallization of compound was performed using ethanol to give fine, pale yellow needle-like crystals,ultra-pure water and cold 2-propanol, re-centrifuged and lyophilized overnight to dryness. The method was follow as the method decriped by Elsharqawy et al., [20].
2.6. Characterization of compound 3 DTQ
Compound 3, 110 mg, 22% yield, m.p. 200.5 °C,UVmax 250 nm and UVmin 380 nm. IR (solid state): 3060 cm−1(vinylic C C-H stretch), 2969–2872 cm−1(C—H stretch of aliphatic groups), H-NMR (600 MHz), δ 6.70 (s,2H), 3. (s, 2H), 3.12–3.06 (septet, j = 6.6,2H), 1.22 (s, 6H), 1.16–1.13 (2d, j = 7.2, 6.6, 12H). ESIMS: 329 [M + 1].
2.7. Cytotoxicity assay
To assess the half maximal cytotoxic concentration (CC50), stock solutions of the test compounds were prepared in 10% DMSO in ddH2O and diluted further to the working solutions with DMEM. The cytotoxic activity of the extracts was tested in VERO-E6 cells by using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) method with minor modifications. Briefly, the cells were seeded in 96 well-plates (100 µl/well at a density of 3 × 105 cells/ml) and incubated for 24 h at 37 °C in 5% CO2. After 24 h, cells were treated with various concentrations of the tested compounds in triplicates. 24 h later, the supernatant was discarded, and cell monolayers were washed with sterile 1x phosphate buffer saline (PBS) 3 times and MTT solution (20 µl of 5 mg/mL stock solution) was added to each well and incubated at 37 °C for 4 h followed by medium aspiration. In each well, the formed formazan crystals were dissolved with 200 µl of acidified isopropanol (0.04 M HCl in absolute isopropanol = 0.073 mL HCL in 50 mL isopropanol). Absorbance of formazan solutions was measured at λ max 540 nm with 620 nm as a reference wavelength using a multi-well plate reader. The percentage of cytotoxicity compared to the untreated cells was determined with the following equation.
The plot of % cytotoxicity versus sample concentration was used to calculate the concentration which exhibited 50% cytotoxicity (CC50) [21].
2.8. Inhibitory concentration 50 (IC50) determination
In 96-well tissue culture plates, 2.4 × 104 Vero-E6 cells were distributed in each well and incubated overnight at a humidified 37 °C incubator under 5% CO2 conditions. The cell monolayers were then washed once with 1x PBS and subjected to virus adsorption (hCoV-19/Egypt/NRC-03/2020 (Accession Number on GSAID: EPI_ISL_430820)) for 1 h at room temperature (RT). The cell monolayers were further overlaid with 100 μl of DMEM containing varying concentrations of the test compounds. Following incubation at 37 °C in a5% CO2 incubator for 72 h, the cells were fixed with 100 μl of 4% paraformaldehyde for 20 min and stained with 0.1% crystal violet in distilled water for 15 min at RT. The crystal violet dye was then dissolved using 100 μl absolute methanol per well and the optical density of the color wasmeasured at 570 nm using Anthos Zenyth 200rt plate reader (Anthos Labtec Instruments, Heerhugowaard, Netherlands). The IC50 of the compound is that required to reduce the virus-induced cytopathic effect (CPE) by 50%, relative to the virus control.
2.9. Statistical analysis
Statistical test were carried out using GraphPad Prism 5.01 software. Data are presented as average of means . the IC 50 and CC50 curve represent the nonlinear fit of Normalize of Transform of the obtained data.
3. Result and discussion
Thymoquinone was used for synthesis hydrothymoquinone(HTQ) and dithymoquinone (DTQ) to study their antiviral activity.
Compounds HTQ and DTQ were synthesis by method descriped in material and methods part and the identification of copounds were follow by UV, IR, H1NMR and ESIMS, The purity of compounds was confirmed by HPLC. And the data were present in supplmantry material.
3.1. Antiviral assay
To identify the proper concentrations to define the antiviral activity of the selected drugs, half-maximal cytotoxic concentration “CC50” was calculated by MTT assay for each individual drug, The sample showed anti-SARS-CoV-2 activity at non-cytotoxic nanomolar concentrations in vitro with low aselectivity index (CC50/IC50, 31.74/23.15 = 1.4). Whereby dimthymoquinone shows high cytotoxicity as in Fig. 1 .
Fig. 1.
Cytotoxic effect of compounds, Dimer (3) and DHT (2). Inhibitory concentration (IC50) values were calculated by nonlinear regression analysis of Graph pad prism software (version 5.01) by plotting log inhibitor versus normalize response (variable slop).
3.2. POM analyses of compounds 1–3
The three compounds 1–3 were also screened for the in-silico POM study to calculate various general properties along with the prediction of antiviral bioactivity. Data was analyzed and comparedwith astandard anti-malaria Artemisinin drug. Osiris and Molinspiration are two cheminformatic based software tools which help in calculation of toxicity risks, molecular properties as well as in the forecasting of bioactivity scoresof the screened compounds.
As our tested compounds 1–3 have a molecular weightof less than 500 g/mol, so they may be highly absorbed because most of the traded drugs, i.e., approximately 80% of them have molecular weights in this range (Table 1 ). In contrast to compounds 1 and 3 which have a negative drug-score, the dimer drug with amolecular weightof 328 g/mol also shows best drug likeness at92% with an exceptional drug-score at72%. The drug likeness of compounds 1 and 2 are −1.2 and −6.33 and their drug-scores are limited to 35% and 22%,respectively (Table 1).
Table 1.
Structure of some compounds of Nigella sativa for antiviral screening against COVID-19.
| Compound | Name, formula and molecular weight |
|---|---|
![]() Compound (1) |
|
![]() Compound (2) |
|
![]() Compound (3) |
|
From Molinspiration data (Table 2 ) it was concluded that the series of tested compounds 1–3 satisfy the rule of Lipinski and behave as a drug and exclusively wherebyonly the dimer compound 3 has anuclear receptor ligand along with enzyme inhibition properties. The cLogP value of the compounds 1–3 falls in the standard range, (i.e., less than 5) therefore these compounds may be highly hydrophilic and thus, meet the criteria of market drugs (Table 3 ).
Table 2.
Osiris analysis of compounds 1–3.
| Compound | Toxicity Risks | Solubility | Drug-Score |
|---|---|---|---|
![]() Compound (1) |
![]() |
![]() |
![]() |
![]() Compound (2) |
![]() |
![]() |
![]() |
![]() Compound (3) |
![]() |
![]() |
![]() |
Table 3.
Molinspiration analysis of compounds 1–3.
| Compound | Molecular Properties | Bioactivity Scores |
|---|---|---|
![]() Compound (1) |
cLogP 1.90 TPSA 34.14 natoms 12 MW 164.20 nON 2 nOHNH 0 nviolations 0 nrotb 1 |
GPCR ligand -1.40 Ion channel modulator -0.31 Kinase inhibitor -1.27 Nuclear receptor ligand -1.47 Protease inhibitor -1.45 Enzyme inhibitor -0.40 |
![]() Compound (2) |
cLogP 3.26 TPSA 40.46 natoms 12 MW 166.22 nON 2 nOHNH 2 nviolations 0 nrotb 1 volume 166.59 |
GPCR ligand -0.92 Ion channel modulator -0.44 Kinase inhibitor -1.06 Nuclear receptor ligand -0.54 Protease inhibitor -1.17 Enzyme inhibitor -0.46 |
![]() Compound (3) |
cLogP 1.70 TPSA 68.28 natoms 24 MW 328.41 nON 4 nOHNH 0 nviolations 0 nrotb 2 volume 310.56 |
GPCR ligand -0.18 Ion channel modulator -0.09 Kinase inhibitor -0.48 Nuclear receptor ligand 0.14 Protease inhibitor -0.10 Enzyme inhibitor 0.10 |
3.3. Identification of antiviral pharmacophore sitesof compounds 1–3
The invention of POM Theory leads us to identify each type of pharmacophore sites with real success, on the basis of semi-empirical data of about 7.000 antibacterial, antifungal, antitumor and antiviral commercial and new drugs. All details of therapeutic applications of POM Theory are given in the literature and the identification of different and various types of pharmacophore sites is well established [22], [23], [24], [25], [26], [27], [28], [29], [30], [31], [32], [33], [34], [35], [36], [37], [38], [39], [40], [41], [42], [43], [44], [45], [46], [47], [48], [49], [50], [51], [52], [53], [54], [55], [56], [57], [58], [59], [60], [61], [62], [63], [64], [65], [66], [67], [68], [69], [70], [71], [72], [73], [74], [75], [76], [77], [78], [79], [80], [81], [82], [83], [84], [85], [86], [87], [88], [89], [90], [91], [92].
The Atomic charge calculation of compounds 1–3 (Table 4 ) show that all oxygen atoms are negatively charged (Fig. 2 ). The distance between any couple of two oxygen can be obtained after optimization of molecular structure by using the Petra program.
Table 4.
Atomic charge of Oxygen of the antiviral (O,O’) pharmacophore sites of 1–3.
| Compd. | O1 | O2 | O3 | O4 | Distance (Å) | Pharmacophore sites | |
|---|---|---|---|---|---|---|---|
| 1 | −032 | −0.32 | --- | --- | O1-O2 | 5.99 | One Medium Antiviral Site |
| 2 | −0.28 | −0.28 | --- | --- | O1-O2 | 5.99 | One Medium Antiviral Site |
| 3 | −0.30 | −0.30 | −0.30 | −0.30 | O1-O2 O3-O4 O1-O3 O2-O4 |
4.12 4.12 5.98 5.98 |
Two Medium Antiviral plus TwoStrong Antiviral Sites |
Fig. 2.
Atomic charge of compounds 1–3.
4. Discussion
COVID-19 is considered a critical threat to public health, and what aggravated the situation is that there is no existing antiviral therapy that is clinically approved for the management of this disease. Searching for new drugs for this disease is a global duty for scientists, so the current study concern searching for new drugs from natural plants have a history in the treatment of many diseases, antiviral, antioxidant, antidiabetic and anticancer.
In this study, three proposed anti-COVID-19 supportive drugs/treatments; Thymoquinone (1), hydrothymoquinone (2), and Dithymoquinone (3) have been analysed, and their pharmacophore sites are characterized via bioinformatic POM analysis. Osiris calculations of analysed compounds reveal that Thymoquinone and dihydrothymoquinone are relatively moresafe than hydroxychloroquine. The dithymoquinoneis the safest one. The most important antiviral activities of dithymoquinone and dihydrothymoquione on agree with the POM results obtained and the tested Thymoquinone derivatives via a synergic mechanism.
In vitro study the results revaled amoung two investigated compound, HTQ has anti-SARS-CoV-2 activity at non-cytotoxic nanomolar concentrations in vitro with low aselectivity index (CC50/IC50, 31.74/23.15 = 1.4). Whereby DTQ shows high cytotoxicity, So the compounds isolated from N.sativia and nigela sativa plant may be used in treatment of CoV-19 after further clinical studies.
Mode of action still has not been identified, however, Molecular docking studies on the TQ showed a notable antiviral activity against a SARS-CoV-19 strain isolated from Egypt, whereby astudy revaled that TQ haspotent antiviral activity through binding to the receptor. Its binding domain on the spike and envelopeproteins of SARSCoV-19, which may hinder virus entry in to the host cell and inhibit its ion chanal and pore-forming activity [92]. The authors of this current study suggest the same mechanism of HTQ inhibition, therefore this will be discussed in afuture study
5. Conclusion
The current study highlight in vitro antiviral studies on two compounds from three major compounds in Nigella sativa depending on bioinformatic analysis, which reveals the importance of three major compounds (TQ, DTQ, and HTQ), as antiviral agents. in vitro antiviral screening on two compounds (DTQ and HTQ) showed the tested drugs exhibited a promising in vitro activity against COVID-19, and have promising antiviral activities, further investigations in clinical trials to determine actual in vivo activity in the treatment of COVID-19 have recommended.
Declaration of Competing Interest
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Acknowledgement
The authors extend their appreciation to the Deputyship for Research& Innovation, Ministry of Education in Saudi Arabia for funding this research work through the project number “IF_2020_NBU_301”.
Footnotes
Supplementary data to this article can be found online at https://doi.org/10.1016/j.bioorg.2021.105587.
Appendix A. Supplementary data
The following are the Supplementary data to this article:
References
- 1.Gharby S., Harhar H., Guillaume D., Roudani A., Boulbaroud S., Ibrahimi M., Ahmad M., Sultana S., Hadda T.B., Chafchaouni-Moussaoui I., Charrouf Z. Chemical investigation of Nigella sativa L. seed oil produced in Morocco. J. Saudi Soc. Agricul. Sci. 2015;14(2):172–177. [Google Scholar]
- 2.Ainane T., Askaoui Z., Elkouali M., Talbi M., Hammouti B., Lahsasni S., Ben Hadda T. Chemical composition and antibacterial activity of essential oil of Nigella sativa seeds from Beni Mellal (Morocco): What is the most important part, Essential Oil or the rest of seeds? J. Mater. Environ. Sci. 2014;5(6):2017–2020. [Google Scholar]
- 3.Forschung A. Drug Res. 1965;15:1227. [Google Scholar]
- 4.Young B.E., Ong S.W.X., Kalimuddin S., Low J.G., Tan S.Y., Loh J., Ng O.-T., Marimuthu K., Ang L.W., Mak T.M., Lau S.K., Anderson D.E., Chan K.S., Tan T.Y., Ng T.Y., Cui L., Said Z., Kurupatham L., Chen M.-C., Chan M., Vasoo S., Wang L.-F., Tan B.H., Lin R.T.P., Lee V.J.M., Leo Y.-S., Lye D.C. Epidemiologic features and clinical course of patients infected with SARS-CoV-2 in Singapore. JAMA. 2020;323(15):1488. doi: 10.1001/jama.2020.3204. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Ou, X., Liu, Y., Lei, X. et al. Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV. Nat Commun 11, 1620 (2020). DOI.org/10.1038/s41467-020-15562-9. [DOI] [PMC free article] [PubMed]
- 6.Huang, C. et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet, https://doi.org/10.1016/S0140-6736(20) 30183-5 (2020). [DOI] [PMC free article] [PubMed]
- 7.Zi-Wei Y.e., Yuan S., Yuen K.S., Fung S.Y., Chan C.P., Jin D.Y. Zoonotic origins of human coronaviruses. Int. J. Biol. Sci. 2020;16(10):1686–1697. doi: 10.7150/ijbs.45472. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Yang Y., Islam M.S., Wang J., Li Y., Chen X. Traditional Chinese Medicine in the Treatment of Patients Infected with 2019-New Coronavirus (SARS-CoV-2): A Review and Perspective. Int. J. Biol. Sci. 2020;16(10):1708–1717. doi: 10.7150/ijbs.45538. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Zhou G., Zhao Q. Perspectives on therapeutic neutralizing antibodies against the Novel Coronavirus SARS-CoV-2. Int. J. Biol. Sci. 2020;16(10):1718–1723. doi: 10.7150/ijbs.45123. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Halawani E. Antibacterial Activity of Thymoquinone and Thymohydroquinone of Nigella sativa L. and Their Interaction with Some Antibiotics. Adv. Biol. Res. 2009;3(5–6):148–152. [Google Scholar]
- 11.Topozada H.H., Masloum H., El-Dakhakhany M. The anti-bacterial properties of Nigella sativa seeds: Active principle with some clinical application. J. Egyptian Medical Association. 1965;48:187–2020. [PubMed] [Google Scholar]
- 12.Banerjee S., Padhye S., Azmi A., Wang Z., Philip P.A., Kucuk O., Sarkar F.H., Mohammad R.M. Review on Molecular and Therapeutic Potential of Thymoquinone in Cancer. Nutr. Cancer. 2010;62(7):938–946. doi: 10.1080/01635581.2010.509832. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Osama A. Badary, Ragia A. Taha, Ayman M. Gamal El-Din & Mohamed H. Abdel- Wahab (2003) Thymoquinone Is a Potent Superoxide Anion Scavenger, Drug Chem. Toxicol., 26:2, 87-98, DOI: 10.1081/DCT-120020404. [DOI] [PubMed]
- 14.Alenzi F.Q., El-Sayed El-Bolkiny Y., Salem M.L. Protective effects of Nigella sativa oil and thymoquinone against toxicity induced by the anticancer drug cyclophosphamide. Br. J. Biomed. Sci. 2010;67(1):20–28. doi: 10.1080/09674845.2010.11730285. [DOI] [PubMed] [Google Scholar]
- 15.El-Dakhakhany M. Studies on the chemical constitution of Egyptian nigella sativa l. Seeds. Ii: The essential oil. Planta Med. 1963;12:465–470. [Google Scholar]
- 16.Khalife K.H., Lupidi G. Nonenzymatic reduction of thymoquinone in physiological conditions. Free Radical Res. 2007;41(2):153–161. doi: 10.1080/10715760600978815. [DOI] [PubMed] [Google Scholar]
- 17.Salem M.L., Hossain M.S. Protective effect of black seed oil from Nigella sativa against murine cytomegalovirus infection. Int. J. Immunopharmacol. 2000;22(9):729–740. doi: 10.1016/s0192-0561(00)00036-9. [DOI] [PubMed] [Google Scholar]
- 18.Sayed M.D. Traditional medicine in health care. J. Ethnopharmacol. 1980;2(1):19–22. doi: 10.1016/0378-8741(80)90023-9. [DOI] [PubMed] [Google Scholar]
- 19.Tesarova H., Svobodova B., Kokoska L., Marsik P., Pribylova M., Landa P., Vadlejch J. Determination of oxygen radical absorbance capacity of black cumin (nigella sativa) seed quinone compounds. Nat. Prod. Commun. 2011;6:213–216. [PubMed] [Google Scholar]
- 20.Elsharkawy R,E,. Abdallah, M, E, Abo Markb, A. Potential Cytotoxic, Antifungal, and Antioxidant Activity of Dithymoquinone and Thymoquinone, Journal of Hunan University(Natural Sciences, 2021,48 (9).
- 21.Mostafa A., Kandeil A., Elshaier Y.A.M.M., Kutkat O., Moatasim Y., Rashad A.A., Shehata M., Gomaa M.R., Mahrous N., Mahmoud S.H., GabAllah M., Abbas H., El Taweel A., Kayed A.E., Kamel M.N., El Sayes M., Mahmoud D.B., El-Shesheny R., Kayali G., Ali M.A. FDA-Approved Drugs with Potent In Vitro Antiviral Activity against Severe Acute Respiratory Syndrome Coronavirus. Pharmaceuticals. 2020;13(12):443. doi: 10.3390/ph13120443. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Ahmed Khodair*, Ahmed A. El-Barbary; Dalia R. Emam; Nabila A. Kheder; Faisal Elmalki; Taibi Ben Hadda. Synthesis, Antiviral, and Molecular Docking Studies of Some Novel 1,2,4-Triazine Nucleosides as Potential Bioactive Compounds. Carbohydrate Res. 500 (2021) 108246. https://doi.org/10.1016/j.carres.2021.108246. [DOI] [PubMed]
- 23.IhsaneELMeskini, LoicToupet, Maria Daoudi, AbdelaliKerbal, Diogo R. M. Moreira, Taibi B. Hadda. Is It Possible For The 2-[(4-chloro-phenyl)-(3,5-dimethylpyrazol-1-yl)-methyl]-malonic acid diethyl ester To Present a Potential Candidate HIV-Integrase Inhibitor On The Basis of Its (O,N,O)-Ligand Structure. Moroccan J. Heterocyclic Chem., Vol 18, No 2 (2019) 36-45. https://doi.org/10.48369/IMIST.PRSM/jmch-v18i2.16384.
- 24.Cruz-Rodriguez L., Rodolfo Barea, Zayas Tamayo A.M., Hochwimmer B., Ben Hadda T., Almalki F. A., Lambert Brown D, Pelaez Figueroa Y., Sanchez Batista L. and Warad I. ELIDAN certificate: BEHAVIOR is the key to save places from Covid-19. J. Biosci. &Biomed. Eng. 1(2), 2020, pp1-21. https://www.researchgate.net/publication/343794128_ELIDAN_certificate_BEHAVIOR_is_the_key_to _save_places_from_Covid-19.
- 25.Faydy M.E., Dahaieh N., Ounine K., Rastija V., Almalki F., Jamalis J., Zarrouk A., Hadda T.B., Lakhrissi B. Synthesis and antimicrobial activity evaluation of some new 7-substituted quinolin-8-ol derivatives: POM analyses, docking, and identification of antibacterial pharmacophore sites. Chem. Data Collect. 2021;31:100593. doi: 10.1016/j.cdc.2020.100593. [DOI] [Google Scholar]
- 26.Hadda T.B., et al. AlteraryDrug Design of Inhibitors of Alzheimer’s Disease (AD): POM and DFT Analyses of Cholinesterase Inhibitory Activity of β-amino di-Carbonyl Derivatives. Mini-Rev. Med. Chem. 2019;19(8):688–705. doi: 10.2174/1389557518666181102102816. [DOI] [PubMed] [Google Scholar]
- 27.Shah Khalid*, Faisal A. Almalki, , Taibi Ben Hadda*, , Ammar Bader, , Tareq Abu-Izneid, , Malika Berredjem, , Eman R. Elsharkawy, Ali M . Alqahtani. “Medicinal Applications of Cannabinoids Extracted from Cannabis sativa (L.): A new Route to Fight against COVID-19?” Current Pharmaceutical Design, 2020. DOI : 10.2174/1381612826666201202125807. [DOI] [PubMed]
- 28.Saud Bawazeer, Asghar Khan, Abdur Rauf, Taibi Ben Hadda, Umer Rashid, Inamullah Khan, Muhammad Asif Nawaz, Md. Sahab Uddin, Ahmed Olatunde, Mohammad Ali Shariati. POM Analysis and Computational Interactions of 8-Hydroxydiospyrin Inside Active Site of Protein Tyrosine Phosphatase 1B. BIOCELL, 2021 45(3): 751-759. doi:10.32604/biocell.2021.014004.
- 29.Rbaa M., Hichar A., Dohare P., Anouar E.H., Lakhrissi Y., Lakhrissi B., Berredjem M., Almalki F., Rastija V., Rajabi M., Hadda T.B., Zarrouk A. Synthesis, Characterization, Biocomputational Modeling and Antibacterial Study of Novel Pyran Based on 8-Hydroxyquinoline. Arab. J. Sci. Eng. 2021;46(6):5533–5542. [Google Scholar]
- 30.Bhat A.R., Dongre R.S., Almalki F.A., Berredjem M., Aissaoui M., Touzani R., Hadda T.B., Akhter M.S. Synthesis, biological activity and POM/DFT/docking analyses of annulated pyrano[2,3-d]pyrimidine derivatives: Identification of antibacterial and antitumor pharmacophore sites. Bioorg. Chem. 2021;106:104480. doi: 10.1016/j.bioorg.2020.104480. [DOI] [PubMed] [Google Scholar]
- 31.Hadda T.B., Rastija V., AlMalki F., Titi A., Touzani R., Mabkhot Y.N., Khalid S., Zarrouk A., Siddiqui B.S. Petra/Osiris/Molinspiration and Molecular Docking Analyses of 3-Hydroxy-Indolin-2-one Derivatives as Potential Antiviral Agents. CAD. 2021;17(1):123–133. doi: 10.2174/1573409916666191226110029. [DOI] [PubMed] [Google Scholar]
- 32.Lakhrissi Y., Rbaa M., Mequedade M., Berkiks I., Mague J., El Hessni A., Ramli Y, Almalki F., Ben Hadda T., Lakhrissi B. Synthesis, Crystal Structure, and Evaluation of Biologycal Activity of Novel Heterocyclic Derivative of 8-Hydroxyquinoline. Available at https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3589130.
- 33.MeriemGuerf, Malika Berredjem, AbdeslemBouzina, Taibi Ben Hadda, Christelle Marminon, KhadidjaOtmaneRachedi, Novel α-sulfamidophosphonates analogues of Fotemustine: Efficient synthesis using ultrasound under solvent-free conditions. MonatsheftefürChemie - Chemical Monthly, (2020). https://doi.org/10.1007/s00706-020-02711-5.
- 34.Farghaly T.A., Abbas I.M., Hassan W.M.I., Lotfy M.S., Al-Qurashi N.T., Hadda T.B. Structure Determination and Quantum Chemical Analysis of 1,3-Dipolar Cycloaddition of Nitrile Imines and New Dipolarophiles and POM Analyses of the Products as Potential Breast Cancer Inhibitors. Russ. J. Org. Chem. 2020;56(7):1258–1271. doi: 10.1134/S1070428020070210. [DOI] [Google Scholar]
- 35.Ahmed Rakib, Saad Ahmed Sami, Nusrat Jahan Mimi, Md. Mustafiz Chowdhury, TaslimaAkter Eva, FirzanNainu, Arkajyoti Paul, Asif Shahriar, Abu MontakimTareq, Nazim Uddin Emon6, Sajal Chakraborty, Sagar Shil4, Sabrina Jahan Mily, Taibi Ben Hadda*, Faisal A. Almalki, Talha Bin Emran*. Immunoinformatics-guided design of an epitope-based vaccine against severe acute respiratory syndromecoronavirus spike glycoprotein. Computers in Biology and Medicine (CBM). Accepted for publication. [DOI] [PMC free article] [PubMed]
- 36.Cruz-Rodriguez, Sanchez Batista, Hochwimmer, Ben Hadda T., Almalki F.A., Dilsiz N., Caparros J.L., Lambert Brown D., Ziarati P., Zayas Tamayo A.M., Pelaez Figueroa Y, Herrera Sanchez M.B., Garcia Hernandez A., Bin Zhao.How to Evaluate Viral Transmission in Enclosed Areas. Medical Geology saving places from Covid-19 Journal of Bioscience & Biomedical Engineering (J. B. Bio. Engine.), 2020, 1(1):1-8.
- 37.Rajendra SukhdeoraoDongre*, Jyostna S. Meshram, Rupali SudhakarraoSelokar, Faisal A. Almalki, Taibi Ben Hadda*. Antibacterial activity of synthetic pyrido[2,3-d]pyrimidines armed with nitrile group: POM analyses and identification of pharmacophore sites of nitriles as important pro-drugs. New J. Chem., 2018, 42, 15610-15617.DOI: 10.1039/C8NJ02081G.
- 38.I. Grib, M. Berredjem, K.O. Rachedi, S.-E. Djouad, S. Bouacida, R. Bahadi, T.-S. Ouk; M. Kadri, T. Ben Hadda, B. Belhania. Novel N-sulfonylphthalimides: Efficient synthesis, X-ray characterization, spectral investigations, POM analyses, DFT computations and antibacterial activity. Journal of Molecular Structure. Available online 14 May 2020, 128423. in press.
- 39.Elsharkawy E.R., Almalki F., Ben Hadda T., Rastija V., Lafridi H., Zgou H. 103850. In press. 2020;100:103850. doi: 10.1016/j.bioorg.2020.103850. [DOI] [PubMed] [Google Scholar]
- 40.Al-Maqtari H.M., Jamalis J., Hadda T.B., Sankaranarayanan M., Chander S., Ahmad N.A., Mohd Sirat H., Althagafi I.I., Mabkhot Y.N. Synthesis, characterization, POM analysis and antifungal activity of novel heterocyclic chalcone derivatives containing acylated pyrazole. Res. Chem. Intermed. 2017;43(3):1893–1907. [Google Scholar]
- 41.S. Boussaidi1, Y. Alaoui, A. Eddiouane1, A. Fitri, A. TouimiBenjelloun, H.Zgou, H. Chaib, M. Bouachrine, M. Hamidi and T. Ben Hadda. Theoretical study of the effect of substitution with alternating donor and acceptor groups on the optoelectronic and photovoltaic properties ofsome oligomers containing thiophene and phenylene.Arabian J. Chemical and Environmental Research. Vol. 3 N° 1 (2016) 51– 63.
- 42.Ghias Uddin, Abdur Rauf, Sania Bibi, Haroon Khan, Taibi Ben Hadda, Mohamed Fawzy Ramadan. Bioactive compounds andbiological activities of Alnusnitida.ZArznei- Gewurzpfla | 22 (3): 121–124 | ERLING Verlag GmbH & Co. KG 2017.
- 43.Hadda T.B., Deniz F.S.S., Orhan I.E., Zgou H., Rauf A., Mabkhot Y.N., Bennani B., Emam D.R., Kheder N.A., Asayari A., Muhsinah A.B., Maalik A. Spiro Heterocyclic Compounds as Potential Anti-Alzheimer Agents (Part 2): Their Metal Chelation Capacity, POM Analyses and DFT Studies. MC. 2021;17(8):834–843. doi: 10.2174/1573406416666200610185654. [DOI] [PubMed] [Google Scholar]
- 44.Bechlem K, Aissaoui M, Belhani B, Rachedi KO, Bouacida S, Bahadi R, Djouad SE, Mansour RB, Bouaziz M, Almalki FA, Ben Hadda T, Berredjem, M. Synthesis, X-ray crystallographic study and molecular docking of new a-sulfamidophosphonates: POM analyses of their cytotoxic activity. J. Molecular Structure2020, 1210, 127990. doi.org/10.1016/j.molstruc.2020.127990.
- 45.Rachedi KT, Ouk T-S,BahadiR,BouzinaA,Djouad S-E,BechlemK,ZerroukiR,BenHaddaT,AlmalkiFA,Berredjem M. Synthesis, DFT and POM analyses of cytotoxicity activity of α-amidophosphonates derivatives: Identification of potential antiviral O,O-pharmacophore site. J. Mol. Structure, 2019, 1197, 196-203. doi.org/10.1016/j.molstruc.2019.07.053.
- 46.Rbaa M., Jabli S., Lakhrissi Y., Ouhssine M., Almalki F.A., Ben Hadda T., Messgo-Moumene S., Zarrouk A., Lakhrissi B. Synthesis, antibacterial properties and bioinformatics computationalanalyses of novel 8-hydroxyquinoline derivatives. Heliyon. 2019;5 doi: 10.1016/j.heliyon.2019.e0268. e026892. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47.Rachedi K.O., Bahadi R., Aissaoui M., Hadda T.B., Belhani B., Bouzina A., Berredjem M. POM Analyses and Molecular Docking of Novel Oxazaphosphinanes: Identification of Antifungal Pharmacophore Site. Indones. J. Chem. 2020;20(2):440. doi: 10.22146/ijc.46375. [DOI] [Google Scholar]
- 48.Titi A., Messali M., Alqurashy B.A., Touzani R., Shiga T., Oshio H., Fettouhi M., Rajabi M., Almalki F.A., Ben Hadda T. Synthesis, Characterization, X-Ray Crystal Study and Bioactivities of Pyrazole Derivatives: Identification of Antitumor, Antifungal and Antibacterial Pharmacophore Sites. J. Mol. Struct. 2019;127625 doi: 10.1016/j.molstruc.2019.127625. [DOI] [Google Scholar]
- 49.Warad, Ismail; Al-Nuri, Mohammed; Ali, Oraib; Abu-Reidah, Ibrahim M.; Barakat, Assem; Ben Hadda, Taibi; Zarrouk, Abdelkader; Radi, Smaail; Touzani, Rachid; Elmsellem, Hicham.Synthesis, Physico-Chemical, Hirschfield Surface and DFT/B3LYP Calculation of Two New Hexahydropyrimidine Heterocyclic Compounds.Iran. J. Chem. Chem. Eng. Research Article Vol. 38, No. 4, 2019.
- 50.Rbaa M., Oubihi A., Anouar E.H., Ouhssine M., Almalki F., Hadda T.B., Zarrouk A., Lakhrissi B. Synthesis of New Heterocyclic Systems Oxazino Derivatives of 8-Hydroxyquinoline: Drug Design and POM Analyses of Substituent Effects on their Potential Antibacterial Properties. Chem. Data Collections. 2019;24:100306. doi: 10.1016/j.cdc.2019.100306. [DOI] [Google Scholar]
- 51.JoazaizulfazliJamalis, FatenSyahira Mohamed Yusof, Subhash Chander, Roswanira Abd. Wahab, Deepak P. Bhagwat, Murugesan Sankaranarayanan, Faisal Almalki, Taibi Ben Hadda. Psoralen Derivatives: Synthetic Strategy and Pharmacological Properties. Anti-Inflammatory & Anti-Allergy Agents Medicinal Chemistry, 2020, 19, 222-239. doi: 10.2174/1871523018666190625170802. [DOI] [PMC free article] [PubMed]
- 52.Amel M. Kamal , Mohamed I. S. Abdelhady , Taibi Ben Hadda. Two novel flavone C-glycosides isolated from Podocarpusgracilior: POM analyses and in-vitro anticancer activity against hepatocellular carcinoma. Int J Pharm Pharm Sci, Vol 11, Issue 7, 2019, 57-62. DOI: 10.22159/ijpps.2019v11i7.33163.
- 53.Amirkhanov V., Rauf A., Hadda T.B., Ovchynnikov V., Trush V., Saleem M., Raza M., Rehman T., Zgou H., Shaheen U., Farghaly T.A. Pharmacophores modeling in terms of prediction of theoretical physico-chemical properties and verification by experimental correlations of Carbacylamidophosphates (CAPh) and Sulfanylamidophosphates (SAPh) Tested as New Carbonic Anhydrase Inhibitors. Mini Rev. Med. Chem. 2019;19(12):1015–1027. doi: 10.2174/1389557519666190222172757. [DOI] [PubMed] [Google Scholar]
- 54.Fouad El Kalai, Tarik Chelfi, Noureddine Benchat, BrahimHacht, Mohamed Bouklah, AbdelmalekElaatiaoui, Said Daoui, Mustapha Allali, Taibi Ben Hadda, Faisal Almalki. New organic extractant based on pyridazinone scaffold compounds: liquid-Liquid extraction study and DFT calculations. Journal of Molecular Structure, 119 (2019) 24-31. DOI 10.1016/j.molstruc.2019.04.033.
- 55.AliasgharJarrahpour, RoghayehHeiran, VéroniqueSinou, Christine Latour, Lamia DjouhriBouktab, Jean Michel Brunel, Javed Sheikhand Taibi Ben Hadda. Synthesis of New β-Lactams Bearing the Biologically Important Morpholine Ring and POM Analyses of Their Antimicrobial and Antimalarial Activities. Iranian Journal of Pharmaceutical Research (2019), 18 (1): 34-48. [PMC free article] [PubMed]
- 56.Hadda T.B., Talhi O., Silva A.S.M., Senol F.S., Orhan I.E., Rauf A., Mabkhot Y.N., Bachari K., Warad I., Farghaly T.A., Althagafi I.I., Mubarak M.S. Cholinesterase Inhibitory Activity of Some semi-Rigid Spiro Heterocycles: POM Analyses and Crystalline Structure of Pharmacophore Site. MRMC. 2018;18(8):711–716. doi: 10.2174/1389557517666170713114039. [DOI] [PubMed] [Google Scholar]
- 57.Javad Ameri Rad, Aliasghar Jarrahpour, Christine Latour, Veronique Sinou, Jean Michel Brunel, Hsaine Zgou, Yahia Mabkhot, Taibi Ben Hadda, Edward Turos. Synthesis and antimicrobial/antimalarial activities of novel naphthalimido trans-β-lactam derivatives. Med Chem Res 26 (2017), 2235–2242. doi:10.1007/s00044-017-1920-z.
- 58.Ghias Uddin, · Nasruddin, · Abdur Rauf, · Haroon khan, Nilufar Z. Mamadalieva, Ajmal Khan, Umar Farooq, Taibi Ben Hadda and · Mohamed Fawzy Ramadan . Phytochemical analysis, urease inhibitory effect and antimicrobial potential of Allium humile. ZeitschriffürArznei- und Gewürzpflanzen, 2018, 22 (4): 173-175.
- 59.Hakkou Z., Maciuk A., Leblais V., Bouanani N.E., Mekhfi H., Bnouham M., Aziz M., Ziyyat A., Rauf A., Hadda T.B., Shaheen U., Patel S., Fischmeister R., Legssyer A. Antihypertensive and vasodilator effects of methanolic extract of Inula viscosa: Biological evaluation and POM analysis of cynarin, chlorogenic acid as potential hypertensive. Biomed. Pharmacother. 2017;93:62–69. doi: 10.1016/j.biopha.2017.06.015. [DOI] [PubMed] [Google Scholar]
- 60.Genc M., Karagoz Genc Z., Tekin S., Sandal S., Sirajuddin M., Hadda T.B., Sekerci M. Design, Synthesis, in vitro Antiproliferative Activity, Binding Modeling of 1,2,4,-Triazoles as New Anti-Breast Cancer Agents. ACSi. 2016:726–737. doi: 10.17344/acsi.2016.2428. [DOI] [PubMed] [Google Scholar]
- 61.Chander S., Tang C.-R., Al-Maqtari H.M., Jamalis J., Penta A., Hadda T.B., Sirat H.M., Zheng Y.-T., Sankaranarayanan M. Synthesis and Study of Anti-HIV-1 RT Activity of 5-benzoyl-4-methyl-1,3,4,5-tetrahydro-2H-1,5-benzodiazepin-2-one derivatives. Bioorg. Chem. 2017;72:74–79. doi: 10.1016/j.bioorg.2017.03.013. [DOI] [PubMed] [Google Scholar]
- 62.Mabkhot Y.N., Arfan M., Zgou H., Genc Z.K., Genc M., Rauf A., Bawazeer S., Ben Hadda T. Saud Bawazeer, and Taibi Ben Hadda. How to Improve Antifungal Bioactivity: POM and DFT Study of some Chiral Amides Derivatives of Diacetyl-L-tartaric Acid and Amines. Res. Chem. Intermed. 2016;42(12):8055–8068. doi: 10.1007/s11164-016-2578-8. [DOI] [Google Scholar]
- 63.Abdur Rauf, Ghias Uddin, Bina S. Siddiqui, Haroon Khan, Mujeeb-ur-Rehman, Ismail Warad,Taibi Ben Hadda, Seema Patel, Ajmal Khan and Umar Farooq. POM Analysis of Phytotoxic Agents from Pistaciaintegerrima Stewart. Current Bioactive Compounds 11 (2015) 231-238.
- 64.Yahia Mabkhot, Alotaibi Alatibi, Nahed El-sayed, Nabila Kheder,Abdul Wadood, Abdur Rauf, Saud Bawazeer, Salim Al-Showiman, Taibi Ben Hadda. Experimental-ComputationalEvaluation of Antimicrobial Activity of Some Novel Armed Thiophene Derivatives. Molecules 2016, 21(2), 222; doi:10.3390/molecules21020222. [DOI] [PMC free article] [PubMed]
- 65.Esra Tatar, SevilŞenkardeş, H.Erdinç Sellitepe, Ş.Güniz Küçükgüzel, ŞengülAlpayKaraoğlu, ArifBozdeveci, Erik De Clercq, Christophe Pannecouque, Taibi Ben Hadda,İlkayKüçükgüzel. Synthesis, prediction of molecular properties and antimicrobial activity of some acylhydrazones derived from N-(arylsulfonyl)methionine. Turkish Journal of Chemistry . 5/1/16, Vol. 40 Issue 3, 510-534.
- 66.Said Tighadouni, SmaailRadi, Muhammad Sirajuddin*, Mehmet Akkurt, NamıkÖzdemir, Matloob Ahmad, Yahia N. Mabkhot and Taibi Ben Hadda. In Vitro Antifungal, Anticancer Activities and POM Analyses of a Novel Bioactive Schiff Base 4-{[(E)-furan-2-ylmethylidene]amino}p-henol: Synthesis, Characterization and Crystal Structure. J.Chem.Soc.Pak., (2016) 38(1):157-165.
- 67.Yahia Mabkhot, Fahad Aldawsari, Salim Al-Showiman, Assem Barakat, Saied Soliman, Mohammad Choudhary, Sammer Yousuf, Taibi Ben Hadda, Mohammad Mubarak. Synthesis, Molecular Structure Optimization, and Cytotoxicity Assay of a Novel 2-Acetyl-3-amino-5-[(2-oxopropyl)sulfanyl]-4-cyanothiophene. Molecules (2016) 21, 214. [DOI] [PMC free article] [PubMed]
- 68.Zara Sajid, Matloob Ahmad*, Sana Aslam, Usman Ali Ashfaq, Ameer Fawad Zahoor, Furqan Ahmad Saddique, Masood Parvez, Abdul Hameed, Sadia Sultan, HsaineZgou and Taibi Ben Hadda. Novel armed pyrazolobenzothiazine derivatives: synthesis, X-ray crystal structure and POM analyses of biological activity against drug resistant clinical isolate of staphylococus aureus, Pharmaceutical Chemistry Journal, Vol. 50, No. 3, June, 2016 (Russian Original Vol. 50, No. 3, March, 2016). DOI 10.1007/s11094-016-1417-y.
- 69.Abdur Rauf, Ghias Uddin, Bina S. Siddiqui, Haroon Khan, Mujeeb-ur-Rehman, Ismail Warad, Taibi Ben Hadda, Seema Patel, Ajmal Khan and Umar Farooq. POM Analysis of Phytotoxic Agents from Pistaciaintegerrima Stewart. Current Bioactive Compounds. Current Bioactive Compounds, 2015, 11(4): 231-238.
- 70.Abdelhady M.I.S., Kamal A.M., Rauf A., Mubarak M.S., Hadda T.B. Taibi Ben Hadda. Bioassay-guided isolation and POM analyses of a new immunomodulatory polyphenolic constituent from Callistemon Viridiflorus. Nat. Prod. Res. 2016;30(10):1131–1135. doi: 10.1080/14786419.2015.1045508. [DOI] [PubMed] [Google Scholar]
- 71.Header E., ElSawy N., El-Boshy M., Basalamah M., Mubarak M.S., Hadda T.B. POM Analyses of Constituents of Rosmarinus officinalis and Their Synergistic Effect in Experimental Diabetic Rats. J Bioanal Biomed. 2015;15(7):018–023. doi: 10.4172/1948-593X.1000118. [DOI] [Google Scholar]
- 72.Ben Hadda T., Genc Z.K., Masand V.H., Nebbache N., Warad I., Jodeh S., Genc M., Mabkhot Y.N., Barakat A., Salgado-Zamora H. Computational POM and DFT Evaluation of Experimental in-vitro Cancer Inhibition of Staurosporine-Ruthenium(II) Complexes: The Power Force of Organometallics in Drug Design. Acta Chim. Slov. 2015;62:679–688. doi: 10.17344/acsi.2015.1357. [DOI] [PubMed] [Google Scholar]
- 73.Javed Sheikh • Vijay Taile • Ajay Ghatole • Vishwas Ingle • Murat Genc • SihamLahsasni • Taibi Ben Hadda• Kishor Hatzade. Antimicrobial/antioxidant activity and POM analyses of novel7-O-b-D-glucopyranosyloxy-3-(4,5-disubstitutedimidazol-2-yl)-4H-chromen-4-ones. Med Chem Res 2015. DOI 10.1007/s00044-015-1326-8.
- 74.Mabkhot Y.N., Aldawsari F.H.D., Al-Showiman S.S., Barakat A., Hadda T.B., Mubarak M.S., SehrishNaz Z.-H., Rauf A. Synthesis, bioactivity, molecular docking and POM anlysis of novel substituted thieno[2,3-b]thiophenes and related congeners. Molecules. 2015;20:1824–1841. doi: 10.3390/molecules20021824. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 75.Moulay H. Youssoufi, Pramod K. Sahu, Praveen K. Sahu, Dau D. Agarwal, Ahmad Mushtaq, MouslimMessali, SihamLahsasni, Taibi Ben Hadda. POM analyses of Antimicrobial Activity of 4H-Pyrimido[2,1-b]Benzothiazole, Pyrazole and Benzylidene Derivatives of Curcumin. Med Chem Res (2015) 24:2381–2392. DOI 10.1007/s00044-014-1297-1.
- 76.Yahia Nasser Mabkhot, Assem Barakat, Sammer Yousuf, M. Iqbal Choudhary, Wolfgang Frey, TaibiBenHadda, Mohammad S. Mubarak.Substitutedthieno[2,3-b]thiophenes and related congeners: Synthesis, <beta>-glucuronidase inhibition activity, crystal structure, and POM analyses. Bioorganic & Medicinal Chemistry. 2014, 22(23):6715–6725. DOI: 10.1016/j.bmc.2014.08.014. [DOI] [PubMed]
- 77.MouslimMessali • Mohamed R. Aouad • Adeeb A.-S. Ali, NadjetRezki • Taibi Ben Hadda • BelkheirHammouti. Synthesis, characterization and POM analysis of novel bioactive imidazolium-based ionic liquids. Medicinal Chemistry Research 2014. DOI 10.1007/s00044-014-1211-x.
- 78.B. Bennani, A. Kerbal, B. F. Baba, M. Daoudi, I. Warad, M. Aljofan, A. M. Alafeefy, V. Masand, T. Ben Hadda. Synthesis, characterization, bioactivity, and POM analyses of isothiochromeno[3,4-e][1,2]oxazines. Medicinal Chemistry Research2013, 22(10) : 4798-4809. doi:10.1007/s00044-012-0392-4.
- 79.Hadda T.B., Bendaha H., Sheikh J., Ahmad M., Warad I. Computational POM Evaluation of Experimental in vitro Trypanosoma cruzi and Mycobacterium Tuberculosis Inhibition of Heterocyclic-2-Carboxylic Acid (3-Cyano-1,4-di-Noxidequinoxalin-2-yl)amide Derivatives. Med. Chem. Res. 2014;23(4):1956–1965. [Google Scholar]
- 80.HarjeetJuneja, DhanashriPanchbhai, Javed Sheikh, Vishwas Ingle, Taibi Ben Hadda. Synthesis, Antibacterial Screening and POM Analyses of Novel Bis-Isoxazolyl/Pyrazoyl-1,3-diols. 2013, Med Chem Res. DOI 10.1007/s00044-013-0755-5.
- 81.Hadda T.B., Srivastava S., Das B., Salgado-Zamora H., Shaheen U., Bader A., Naseer M.M. POM Analyses of Antimicrobial activity of Some 2,3-Armed 4,5,6,7-tetrahydro-1-Benzothiophenes: Favourable and UnfavourablePhysico-chemical Parameters in Design of Antibacterial and Mycolytic Agents. Med. Chem. Res. 2014;23(2):995–1003. doi: 10.1007/s00044-013-0707-0. [DOI] [Google Scholar]
- 82.Hadda T.B., Ahmad M., Sultana S., Shaheen U., Bader A., Srivastava S., Das B., Salgado-Zamora H. POM analyses for Antimicrobial evaluation of Thienopyrimidinones Derivatives: A Rapid Method for Drug Design. Med. Chem. Res. 2014;23(1):16–24. doi: 10.1007/s00044-013-0614-4. [DOI] [Google Scholar]
- 83.Ben Hadda T., Mouhoub R., Jawarkar R., Masand V., Warad I. POM analyses of antitrypanosomal activity of 2-iminobenzimidazoles: favorable and unfavorable parameters for drugs optimization. Med. Chem. Res. 2013;22(5):2437–2445. [Google Scholar]
- 84.Ben Hadda T., Ali M.A., Masand V., Gharby S., Fergoug T., Warad I. Tautomeric Origin of Dual Effects of N1-nicotinoyl-3-(4’-hydroxy-3’-methyl phenyl)-5-[(sub)phenyl]-2-pyrazolines on Bacterial and Viral Strains: POM Analyses as New Efficient Bioinformatics' Platform to Predict and Optimize Bioactivity of Drugs. Med. Chem. Res. 2013;22(3):1438–1449. doi: 10.1007/s00044-012-0143-6. [DOI] [Google Scholar]
- 85.Ben Hadda T., Fathi J., Chafchaouni I., Masand V., Charrouf Z., Chohan Z.H., Jawarkar R., Fergoug T., Warad I. Computational POM and 3D-QSAR Evaluation of Experimental in vitro HIV-1 Integrase Inhibition of Amide-containing di-Ketoacids. Med. Chem. Res. 2013;22(3):1456–1464. doi: 10.1007/s00044-012-0120-0. [DOI] [Google Scholar]
- 86.Ben Hadda T., Fergoug T., Warad I., Masand V., Sheikh J. POM as a quick bioinformatic platform to select flavonoids and their metabolites as potential and efficient HIV-1 integrase inhibitors. Res. Chem. Intermed. 2013;39:1227–1244. doi: 10.1007/s11164-012-0679-6. [DOI] [Google Scholar]
- 87.Mahajan D.T., Masand V.H., Patil K.N., Hadda T.B., Jawarkar R.D., Thakur S.D., Rastija V. Vesna Rastija, CoMSIA and POM analyses of anti-malarial activity of synthetic prodiginines. Bioorg. Med. Chem. Lett. 2012;22(14):4827–4835. doi: 10.1016/j.bmcl.2012.05.115. [DOI] [PubMed] [Google Scholar]
- 88.T. Ben Hadda, T. Fergoug and I. Warad. POM Theoretical Calculations and Experimental Verification of Antibacterial Potentialof 5-Hydroxy-4-(Substituted-Amino)-2(5H)-Furanones. Res Chem Intermed (2013) 39:1963–1971. DOI: 10.1007/s11164-012-0729-0. (Impact Factor = 0.715).
- 89.Fathi J., Masand V., Jawarkar R., Mouhoub R., Ben Hadda T. POM as Efficient Tools to Predict and Improve Both Antibacterial and Antifungal Activity of Aryl Aldazines. J. Comput. Method. Mol. Design. 2011;1(3):57–68. [Google Scholar]
- 90.Masand V.H., Patil K.N., Jawarkar R.D., Ben Hadda T., Youssoufi M.H., Alafeefy A.A. Exploring interactions of 2-Amino-6-arylsulfonylbenzonitrile derivatives as non-nucleoside reverse transcriptase inhibitors of H IV-1 using docking studies. J. Comput. Method. Mol. Design. 2011;1(3):39–48. [Google Scholar]
- 91.A. Jarrahpour, J. Fathi, M. Mimouni, T. Ben Hadda, J. Sheikh, Z. H. Chohan and A. Parvez. Petra, Osiris and Molinspiration (POM) Together as a Successful Support in Drug Design: Antibacterial Activity and Biopharmaceutical Characterization of Some Azo Schiff Bases. Med Chem Res (2012) 21(8): 1984–1990. DOI 10.1007/s00044-011-9723-0.
- 92.Badary OA, Hamza MS, Tikamdas R. Thymoquinone: A Promising Natural Compound with Potential Benefits for COVID-19 Prevention and Cure. Drug Des Devel Ther. 2021;15:1819-1833.https://doi.org/10.2147/DDDT.S308863. [DOI] [PMC free article] [PubMed]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.






















